5 Most Undervalued Pharma Stocks To Buy According To Analysts

4. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Share Price Upside: 49%

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is an Ireland based biopharmaceutical firm that develops treatments for cancer and sleep disorders among others. Its shares are rated Strong Buy on average and analysts have penciled in a $68 share price upside based on the average share price target of $201.06.

After digging through 910 hedge fund holdings for this year’s June quarter, Insider Monkey found that 44 had bought the company’s shares. Jazz Pharmaceuticals plc (NASDAQ:JAZZ)’s biggest hedge fund investor is Robert Pohly’s Samlyn Capital through its $166 million stake.

Follow Jazz Pharmaceuticals Plc (NASDAQ:JAZZ)